1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
8 |
| Hold |
2 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | - |
| Net profit | -8.27M | 194.49% |
| EBITDA | -8.17M | 223.62% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €67.25M |
Number of shares | 100.36M |
52-week high/low | €1.32 - €0.64 |
| Dividends | No |
Beta | 1.15 |
P/E ratio | -3.13 |
PEG ratio | 0.12 |
P/B ratio | -20.88 |
P/S ratio | 0.00 |
Company profile
| Name | Oncolytics Biotech |
| CEO | Jared Kelly |
| Employees | 29 |
